Fyrwald J Erik, Chief Executive Officer of International Flavors & Fragrances (IFF), has filed 36 Form 4 transactions across two companies, with a pronounced buying bias. His open-market purchases total $5,000,037.52, while he has recorded zero open-market sales. The most significant buying occurred in March 2026, when he acquired IFF shares in two transactions: $933,224.06 on March 13 and $61,980.03 on March 12. These purchases represent the only "P" (open-market purchase) codes in his recent filing history, signaling conviction in the stock at that time.
The remainder of his activity is dominated by compensation-related transactions. He has received recurring "A" (grant or award) allocations in Eli Lilly (LLY), typically valued at approximately $9,916 per event, occurring monthly from October 2025 through July 2026. Two larger LLY grants on November 17, 2025, were each valued at $219,999.60. His IFF activity includes "M" (option exercises) and "F" (shares withheld for tax) transactions, with the latter totaling $549,698.03 on May 1, 2026, and $641,155.95 on April 1, 2026. These tax-withholding events are automatic and not discretionary trades.
The pattern reveals a clear directional bias: Fyrwald has been a net buyer of IFF stock in the open market, with no corresponding sales, while his LLY holdings have grown exclusively through scheduled compensation grants. The total acquired value across all transactions stands at $658,166.39, though this figure is dwarfed by his direct purchases. The absence of any "S" (open-market sale) codes across his entire filing history underscores a consistent accumulation posture, particularly in IFF, where his March purchases suggest deliberate capital deployment at that price point.
AI-assisted summary